Skip to main content
Fig. 8 | BMC Pulmonary Medicine

Fig. 8

From: Suppressor of variegation 3–9 homologue 1 impairment and neutrophil-skewed systemic inflammation are associated with comorbidities in COPD

Fig. 8

The levels of SUV39H1 are significantly reduced in COPD patients with high comorbidities. The levels of SUV39H1 protein expression in PBMCs from normal control (n = 13) and COPD subjects (L-Com: ≤ 1 comorbidity, n = 15 vs. H-Com: ≥ 2 comorbidities, n = 15) were measured by immunoblotting. The protein intensity values for SUV39H1 were normalized to the actin value and are expressed as the fold change over the control value. **p < 0.01

Back to article page